Literature DB >> 20134459

The search beyond statins.

Melinda Wenner Moyer.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20134459     DOI： 10.1038/nm0210-150

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

2.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766

3.  Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Authors:  John J P Kastelein; Fatima Akdim; Erik S G Stroes; Aeilko H Zwinderman; Michiel L Bots; Anton F H Stalenhoef; Frank L J Visseren; Eric J G Sijbrands; Mieke D Trip; Evan A Stein; Daniel Gaudet; Raphael Duivenvoorden; Enrico P Veltri; A David Marais; Eric de Groot
Journal:  N Engl J Med       Date:  2008-03-30       Impact factor: 91.245

4.  Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice.

Authors:  Hong-Wei Wang; Ping-Yen Liu; Naotsugu Oyama; Yoshiyuki Rikitake; Shiro Kitamoto; Jonathan Gitlin; James K Liao; William A Boisvert
Journal:  FASEB J       Date:  2008-06-12       Impact factor: 5.191
  4 in total
  7 in total

1.  Does upsizing statins have a downside?

Authors:  Andrew J Brown
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

2.  A small-molecule screening strategy to identify suppressors of statin myopathy.

Authors:  Bridget K Wagner; Tamara J Gilbert; Jun-ichi Hanai; Shintaro Imamura; Nicole E Bodycombe; Robin S Bon; Herbert Waldmann; Paul A Clemons; Vikas P Sukhatme; Vamsi K Mootha
Journal:  ACS Chem Biol       Date:  2011-07-15       Impact factor: 5.100

3.  Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.

Authors:  Anshul Gupta; Jennifer J Harris; Jianrong Lin; James P Bulgarelli; Bruce K Birmingham; Scott W Grimm
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  Induction of C-X-C chemokine receptor type 7 (CXCR7) switches stromal cell-derived factor-1 (SDF-1) signaling and phagocytic activity in macrophages linked to atherosclerosis.

Authors:  Wanshu Ma; Yiwei Liu; Nicholas Ellison; Jianzhong Shen
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

Review 5.  The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol.

Authors:  Steve Poirier; Gaétan Mayer
Journal:  Drug Des Devel Ther       Date:  2013-10-04       Impact factor: 4.162

6.  Genetic interaction networks mediate individual statin drug response in Saccharomyces cerevisiae.

Authors:  Bede P Busby; Eliatan Niktab; Christina A Roberts; Jeffrey P Sheridan; Namal V Coorey; Dinindu S Senanayake; Lisa M Connor; Andrew B Munkacsi; Paul H Atkinson
Journal:  NPJ Syst Biol Appl       Date:  2019-10-03

7.  Caenorhabditis elegans pathways that surveil and defend mitochondria.

Authors:  Ying Liu; Buck S Samuel; Peter C Breen; Gary Ruvkun
Journal:  Nature       Date:  2014-04-02       Impact factor: 49.962
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.